Suprotik Basu is Chief Executive Officer of the Office of the UN Secretary-General’s Special Envoy for Health in Agenda 2030 and for Malaria.
He concurrently serves as CEO of the Global Health Alliance, an initiative of the Office of the Special Envoy focused on bringing business leaders and business approaches into the efforts to achieve the world’s global health goals. During his tenure as CEO since June 2013, over $5 billion in additional resources for child and maternal health have been mobilized, and a new Global Financing Facility for women’s and children’s health launched.
From 2007 to 2011, Mr. Basu co-chaired the resource mobilization activities for the global Roll Back Malaria Partnership through its Harmonization Working Group and mobilized over US$3.5 billion in additional resources for malaria control efforts in sub-Saharan Africa and South Asia. Deaths from malaria have now been slashed by over 50%, with consideration now being given to the worldwide eradication of the disease.
Prior to his appointment as CEO, Mr. Basu was Managing Director of the Office of the UN Secretary-General’s Special Envoy for Malaria. He previously served as Public Health Specialist at the World Bank (2002-2007), where he provided implementation support for over US$700 million in grants and interest-free loans across 18 countries in sub-Saharan Africa and India.
Mr. Basu serves on the boards of the MDG Health Alliance, the Global Business Coalition for Health, the Roll Back Malaria Partnership, and Princess House, Inc. He holds undergraduate and graduate degrees from The Johns Hopkins University, and lives in New York City.